Table 3.
Univariable and multivariable analysis of influence of waiting time on disease-free survival and overall survival in patients treated with neoadjuvant therapy followed by esophagectomy for esophageal cancer
Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
HR | 95 % CI | p value | HR | 95 % CI | p value | |
Disease-free survival | ||||||
Additional week waiting time | 0.96 | 0.88–1.05 | 0.362 | 0.96 | 0.88–1.04 | 0.312 |
ypT stage | ||||||
T0 | Reference | – | – | Reference | ||
T1-2 | 1.55 | 0.69–3.47 | 0.288 | 1.22 | 0.54–2.79 | 0.635 |
T3-4a | 3.94 | 1.89–8.25 | <0.001 | 2.40 | 1.10–5.22 | 0.028 |
ypN stage | ||||||
N0 | Reference | – | – | Reference | – | – |
N1 | 1.83 | 1.11–3.03 | 0.019 | 1.72 | 1.03–2.88 | 0.039 |
N2-3 | 4.42 | 2.77–7.03 | <0.001 | 3.09 | 1.81–5.25 | <0.001 |
Radicality | ||||||
R0 | Reference | – | – | Reference | – | – |
R1 | 4.41 | 2.46–7.91 | <0.001 | 1.93 | 1.00–3.70 | 0.049 |
Overall survival | ||||||
Additional week waiting time | 1.00 | 0.91–1.08 | 0.910 | 0.96 | 0.88–1.05 | 0.372 |
ypT stage | ||||||
T0 | Reference | – | – | Reference | – | – |
T1-2 | 0.95 | 0.45–2.02 | 0.895 | 0.71 | 0.33–1.54 | 0.385 |
T3-4a | 2.54 | 1.31–4.94 | 0.006 | 1.46 | 0.71–3.00 | 0.300 |
ypN stage | ||||||
N0 | Reference | – | – | Reference | – | – |
N1 | 2.07 | 1.25–3.43 | 0.005 | 2.04 | 1.21–3.43 | 0.007 |
N2-3 | 4.15 | 2.57–6.69 | <0.001 | 3.04 | 1.74–5.33 | <0.001 |
Radicality | ||||||
R0 | Reference | – | – | Reference | – | – |
R1 | 4.40 | 2.46–7.87 | <0.001 | 1.90 | 0.99–3.66 | 0.055 |
HR hazard ratio, CI confidence interval
Analysis was performed using Cox regression model. Bold values indicate statistically significant results (e.g., p < 0.05). Only waiting time and variables with p < 0.1 from univariable analysis are reported and were used for multivariable analysis